XML 44 R26.htm IDEA: XBRL DOCUMENT v3.20.2

Segment Information (Tables)

3 Months Ended

Sep. 30, 2020

Segment Reporting, Revenue Reconciling Item [Line Items]

Revenue from External Customers by Geographic Areas [Table Text Block]

The following table presents revenue by geographic area:

			Three Months Ended September 30,
(in millions)			2020						2019
United States			$	37,976					$	36,310
International			1,093						1,035
Total segment revenue			39,069						37,345
Corporate (1)			(4)						(4)
Total revenue			$	39,065					$	37,341

(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:

			Three Months Ended September 30,
(in millions)			2020						2019
Pharmaceutical Distribution and Specialty Solutions (1) (2)			$	34,916					$	33,212
Nuclear and Precision Health Solutions			196						216
Pharmaceutical segment revenue			35,112						33,428
Medical distribution and products (3)			3,438						3,446
Cardinal Health at-Home Solutions			519						471
Medical segment revenue			3,957						3,917
Total segment revenue			39,069						37,345
Corporate (4)			(4)						(4)
Total revenue			$	39,065					$	37,341

(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services".

(2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.

(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.

(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

The following table presents segment profit by reportable segment and Corporate:

			Three Months Ended September 30,
(in millions)			2020						2019
Pharmaceutical			$	402					$	398
Medical			230						170
Total segment profit			632						568
Corporate			(1,256)						(5,832)
Total operating loss			$	(624)					$	(5,264)

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)			September 30, 2020						June 30, 2020
Pharmaceutical			$	22,809					$	22,398
Medical			14,985						14,691
Corporate			3,933						3,677
Total assets			$	41,727					$	40,766

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingRevenueReconcilingItemLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration